---
title: "Forms Syntron: Yiqun Holdings reduced its stake by 2.25% and completed the transaction"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258892487.md"
description: "Forms Syntron announced that its controlling shareholder, Yiqun Holdings, will reduce its holdings in the company by 11,939,400 shares through centralized bidding and block trading from September 3 to September 24, 2025, accounting for 2.25% of the total share capital. After the reduction, Yiqun Holdings will hold 107 million shares, and its shareholding ratio will decrease to 20.18%"
datetime: "2025-09-25T12:53:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258892487.md)
  - [en](https://longbridge.com/en/news/258892487.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258892487.md)
generator: "portal-rs"
---

# Forms Syntron: Yiqun Holdings reduced its stake by 2.25% and completed the transaction

Forms Syntron announced that its controlling shareholder, Yiqun Holdings, reduced its holdings in the company by a total of 11,939,400 shares through centralized bidding and block trading from September 3 to September 24, 2025, accounting for 2.25% of the total share capital. The reduction was made in 5 transactions: 2.2 million shares at 41.27 yuan/share, 3.1064 million shares at 40.98 yuan/share, 408,000 shares at 37.2 yuan/share, 235,000 shares at 36.86 yuan/share, and 5.99 million shares at 30.36 yuan/share; after the reduction, the remaining shares held are 107 million shares, with a holding ratio of 20.18%. The reduction plan has been completed

### Related Stocks

- [300468.CN](https://longbridge.com/en/quote/300468.CN.md)

## Related News & Research

- [HM Exploration shares gain DTC eligibility for US trading on OTCQB](https://longbridge.com/en/news/296448374.md)
- [Heineken Holding N.V. reports transactions under its current share buyback programme | HKHHY Stock News](https://longbridge.com/en/news/296773285.md)
- [Algorand: v5 Mainnet goes live - 22 Aug 2026](https://longbridge.com/en/news/296687546.md)
- [NexgenRx Announces Second Quarter Results (With Substantial Increases in Revenue, EBITDA and Financial Position) and Declaration of Dividend](https://longbridge.com/en/news/296536656.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**